198 related articles for article (PubMed ID: 23687950)
21. Computational toxicology--a tool for early safety evaluation.
Merlot C
Drug Discov Today; 2010 Jan; 15(1-2):16-22. PubMed ID: 19835978
[TBL] [Abstract][Full Text] [Related]
22. Juvenile animal toxicity study designs to support pediatric drug development.
Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
[TBL] [Abstract][Full Text] [Related]
23. Human biology-based drug safety evaluation: scientific rationale, current status and future challenges.
Kenna JG
Expert Opin Drug Metab Toxicol; 2017 May; 13(5):567-574. PubMed ID: 28150517
[TBL] [Abstract][Full Text] [Related]
24. Metabolic and toxicological considerations of botanicals in anticancer therapy.
Fimognari C; Ferruzzi L; Turrini E; Carulli G; Lenzi M; Hrelia P; Cantelli-Forti G
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):819-32. PubMed ID: 22540949
[TBL] [Abstract][Full Text] [Related]
25. Computational modeling of P450s for toxicity prediction.
Mishra NK
Expert Opin Drug Metab Toxicol; 2011 Oct; 7(10):1211-31. PubMed ID: 21864218
[TBL] [Abstract][Full Text] [Related]
26. Is There a Space-Based Technology Solution to Problems with Preclinical Drug Toxicity Testing?
Hammond T; Allen P; Birdsall H
Pharm Res; 2016 Jul; 33(7):1545-51. PubMed ID: 27183841
[TBL] [Abstract][Full Text] [Related]
27. Tools to investigate and avoid drug-hypersensitivity in drug development.
Corsini E; Casula M; Tragni E; Galbiati V; Pallardy M
Expert Opin Drug Discov; 2018 May; 13(5):425-433. PubMed ID: 29405076
[TBL] [Abstract][Full Text] [Related]
28. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
[TBL] [Abstract][Full Text] [Related]
29. Metabolites in safety testing.
Robison TW; Jacobs A
Bioanalysis; 2009 Oct; 1(7):1193-200. PubMed ID: 21083045
[TBL] [Abstract][Full Text] [Related]
30. OrganDots--an organotypic 3D tissue culture platform for drug development.
Sundstrom L; Biggs T; Laskowski A; Stoppini L
Expert Opin Drug Discov; 2012 Jun; 7(6):525-34. PubMed ID: 22607235
[TBL] [Abstract][Full Text] [Related]
31. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
Powley MW; Frederick CB; Sistare FD; DeGeorge JJ
Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
[TBL] [Abstract][Full Text] [Related]
32. Drugs in control samples in nonclinical safety studies: a reconsideration.
Zimmer D
Bioanalysis; 2016 May; 8(10):1003-7. PubMed ID: 27080047
[No Abstract] [Full Text] [Related]
33. The role for microRNAs in drug toxicity and in safety assessment.
Marrone AK; Beland FA; Pogribny IP
Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):601-11. PubMed ID: 25739314
[TBL] [Abstract][Full Text] [Related]
34. Assessing drug safety in human tissues - what are the barriers?
Holmes A; Bonner F; Jones D
Nat Rev Drug Discov; 2015 Aug; 14(8):585-7. PubMed ID: 26205467
[No Abstract] [Full Text] [Related]
35. Toxicity testing in chemical safety evaluation.
Bus JS
Curr Protoc Toxicol; 2007 Feb; Chapter 19():Unit19.2. PubMed ID: 23045142
[TBL] [Abstract][Full Text] [Related]
36. Future of toxicology--mechanisms of toxicity and drug safety: where do we go from here?
Stevens JL
Chem Res Toxicol; 2006 Nov; 19(11):1393-401. PubMed ID: 17112225
[TBL] [Abstract][Full Text] [Related]
37. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
38. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA
Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138
[TBL] [Abstract][Full Text] [Related]
39. Inbred strains should replace outbred stocks in toxicology, safety testing, and drug development.
Festing MF
Toxicol Pathol; 2010 Aug; 38(5):681-90. PubMed ID: 20562325
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceutical excipient development: the need for preclinical guidance.
Baldrick P
Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
